Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P5KA | ISIN: CA75671E1097 | Ticker-Symbol: 4YX
Frankfurt
13.05.26 | 08:08
0,020 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
RED LIGHT HOLLAND CORP Chart 1 Jahr
5-Tage-Chart
RED LIGHT HOLLAND CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0200,03319:29

Aktuelle News zur RED LIGHT HOLLAND Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15:14Red Light Holland Corp.: Red Light Holland Announces Shareholder Approval of Name Change and Announces Voting Results from 2026 Annual General and Special Meeting of Shareholders349Toronto, Ontario--(Newsfile Corp. - May 13, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light Holland" or the "Company") is pleased to announce that shareholders...
► Artikel lesen
FrRed Light Holland Corp: Red Light talks publication of psilocybin clinical trial11
RED LIGHT HOLLAND Aktie jetzt für 0€ handeln
FrRed Light Holland Corp.: Red Light Holland Highlights Publication of Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, with Filament Health Holding the Exclusive License to the Data and Intellectual Property370Peer-reviewed results published yesterday (May 7, 2026) in JAMA Network Open demonstrate that a single dose of psilocybin meaningfully reduced cocaine use in adults with cocaine use disorder over...
► Artikel lesen
DoRed Light Holland Corp: Red Light expands PEX010 distribution in North America4
DoRed Light Holland Corp.: Red Light Holland's Wholly Owned Subsidiary, Filament Health, Expands Distribution of PEX010 Across Canadian and U.S. Research Institutions378Toronto, Ontario--(Newsfile Corp. - May 7, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company") is an Ontario-based organization advancing innovation...
► Artikel lesen
05.05.Red Light Holland Corp: Red Light plans rebranding, including name change3
30.04.Red Light Holland Corp: Red Light Holland closes Filament Health acquisition5
30.04.Red Light Holland Corp.: Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution367Establishes a vertically integrated platform spanning pharmaceutical-grade botanical drug development and global consumer distributionAdds Filament's extensive intellectual property portfolio, including...
► Artikel lesen
29.04.Red Light Holland Corp: Red Light Holland receives court OK for Filament buy5
29.04.Red Light Holland Corp.: Red Light Holland Announces Filament Health Obtains Final Order for Proposed Arrangement330Toronto, Ontario--(Newsfile Corp. - April 29, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Filament Health Corp. (OTC: FLHLF) ("Filament")...
► Artikel lesen
27.04.Red Light Holland Corp: Red Light target Filament receives shareholder approval2
27.04.Red Light Holland Corp.: Red Light Holland Announces Filament Health Shareholder Approval of Acquisition331Toronto, Ontario--(Newsfile Corp. - April 27, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light") and Filament Health Corp. (OTC: FLHLF) ("Filament") are pleased...
► Artikel lesen
24.04.Red Light Holland Corp: Red Light target talks PEX010 clinical supply shipments6
24.04.Red Light Holland Corp.: Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments400Toronto, Ontario--(Newsfile Corp. - April 24, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company") is pleased to highlight continued expansion and...
► Artikel lesen
21.04.Red Light Holland Corp: Red Light notes psychedelic policy shift for Kala Bio30
21.04.Red Light Holland Corp: Red Light notes publication points to repeatable models8
20.04.Red Light Holland Corp.: Red Light Holland Highlights U.S. FDA-Authorized Study Supporting Multi-Session Psilocybin Therapy using Filament Health's Patented PEX010 Botanical Drug Candidate381Study conducted under U.S. FDA Investigational New Drug (IND) authorization by Dr. Anthony Back at the University of WashingtonSecond psilocybin session showed meaningful improvements in anxiety...
► Artikel lesen
07.04.Red Light Holland Corp: Red Light target expands PEX010 clinical network12
07.04.Red Light Holland Corp.: Red Light Holland Reports Continued Expansion of Filament Health's PEX010 Clinical Network with New License Agreements and Research Shipments528Three new license agreements signed and two research shipments completed in March 2026, spanning institutions in Australia, the United Kingdom, and CanadaToronto, Ontario--(Newsfile Corp. - April...
► Artikel lesen
02.04.Red Light Holland Corp: Red Light to support Carhart-Harris Lab for study7
Weiter >>
51 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1